StockTipsArenaBeta

BUY Laurus Labs Ltd — Chandan Taparia, Motilal Oswal

BUYLaurus Labs Ltd
Laurus Labs share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))26 Oct 2026via LiveMint Markets

Entry₹2,075Inferred
Target₹2,180
Total upside +5.06%
Stop loss₹1,990-4.10% risk
CMP₹2,142Just now
Active+3.23%+1.77%upside left 13d left
Follow Chandan Taparia for new calls(31% target hit, 262 closed calls)Get alertsWatch LAURUSLABS for new buy/sell callsGet alertsSee 3 other Swing calls on LAURUSLABSSee 144 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 27 Oct, 4:05 pm IST
3 supporting2 neutral2 opposing
Supports the BUY call (3)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·27 Oct · today

Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside

NewsEt-Markets·16 Oct · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·16 Oct · 2w ago

Neutral / worth noting (2)

Q2 FY27 results scheduled — board meets 29 Oct 2026

BSE · Board Meeting·In 2 days

(opens in new tab)

Laurus Labs invested INR 1.078 billion in its joint venture KRKA Pharma Private Limited via a rights issue, maintaining its 49% stake.

BSE · Company Update·14 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·27 Oct · today

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·27 Jul · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Laurus Labs

All analyst calls on Laurus Labs

More from Chandan Taparia, Motilal Oswal

Every call and its outcome